ESMINT 2024: What's New in Neurointervention

SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. 

The European Society for Minimally Invasive Neurological Therapy (ESMINT) Annual Congress is unique, not only because it addresses issues and trends pertinent to Europe, but because it also provides a worldwide perspective that features cutting edge science, industry symposia, a novel “startup alley” and the latest advancements in therapies and techniques affecting the market for the minimally invasive treatment of ischemic and hemorrhagic stroke.

In this downloadable article, SmartTRAK highlights the top news, research and advances in neurointervention from ESMINT 2024 held September 4-6 in Marseille, France. This includes:

• Innovation in Access Devices
  • Over the last several years, companies have been developing new catheters and access devices designed to better navigate difficult anatomy and tortuous vessels to reach target vessels and achieve rapid access during neurovascular intervention. With this in mind, two companies have developed novel guidewires with remotely shapeable tips that can be used to address different types of anatomy and facilitate successful catheterization ... (read more)
• Advances in Mechanical Thrombectomy from the Following Companies
  • Rapid Medical
  • Q’Apel Medical
  • Balt
  • WallabyPhenox
  • Acandis 
  • Stryker
  • Medtronic
  • PenumbraPenumbra
  • JNJ MedTech
  • Terumo Neuro
  • Vesalio
• Current and Emerging Flow Diverters
  • Since the FDA approved Medtronic’s Pipeline Embolization Device in 2011, flow diversion has revolutionized the treatment of intracranial aneurysms and allowed clinicians to treat a wider range of aneurysms in more complex anatomies. Today, flow diverters continue to evolve and almost every manufacturer of neurovascular devices currently has or is developing a flow diverter as part of its hemorrhagic stroke portfolio. (read more)
    
    

Click the button below to download and read the comprehensive "ESMINT 2024: What's New in Neurointervention" Market Outlook article by Anne Staylor, SmartTRAK Executive Editor VP and GM, Neuro Therapies.

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.